v1
Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
Identifier:nobleid.org/w1/20260515/D6F900FD
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/D6F900FD)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims